This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
There were 21 patients (71% men) in the irremovable TCC group and 20 (65% men) in the TCC group. The mean age of the patients was 50.7 years (age range: 29 -65) in the irremovable TCC group and 51 years (age range: 23 -65) in the TCC group. It was not stated whether some patients refused to participate, or were excluded for any reason from the initial study sample.
Study design
This was a prospective, randomised clinical trial that was, presumably, carried out at a single centre. The patients were allocated to study groups using a prepared random number table. The length of follow-up was 12 weeks. Overall, 7 patients were lost to the follow-up assessment (4 in the irremovable TCC group and 3 in the TCC group). Reasons for loss to follow-up were not reported. The outcome assessment was not blinded.
Analysis of effectiveness
The analysis of the clinical study was conducted on an intention to treat basis. However, results were also reported for when patients lost to follow-up were not taken into consideration. The outcome measures used in the clinical study were:
the proportion of patients with ulcers that healed in less than or equal to 12 weeks; the median healing times for patient with ulcers healing in the 12-week period;
the frequency of complications (defined as any potential side effect from the treatment); the weight of the devices; and the times of placement and removal of the devices.
The study groups were comparable at baseline in terms of the demographics and clinical characteristics.
Effectiveness results
The proportion of patients with ulcers that healed in less than or equal to 12 weeks was 74% (+/-45) in the TCC group and 80% (+/-41) in the irremovable TCC group, (p=0.65). Excluding patients lost to follow-up, the corresponding proportions were 93% (+/-26) and 94% (+/-24), (p=0.97).
The median healing time for patient with ulcers healing in the 12-week period was 5 weeks (first quartile 3 -third quartile 7) for the TCC group and 4 weeks (first quartile 3 -third quartile 7) for the irremovable TCC group.
The frequency of complications was 65% with TCC and 38% with irremovable TCC, (p=0.09). The analysis showed a relative risk reduction (RR) of 41% with irremovable TCC and an absolute RR of 27% (95% confidence interval, CI: 4.3 -58). Most of the complications were simple local skin maceration. When episodes of maceration were excluded, the complication rates dropped to 46% in the TCC group and 13% in the irremovable TCC group. This corresponded to a relative RR of 71% and an absolute RR of 33% (95% CI: -1.2 -67; p=0.06). One amputation (a single toe amputation) was observed in each group.
The medium-sized irremovable TCC weighed 1.1 kg in comparison with 1.5 kg for the TCC, (p=0.0009).
The large-sized irremovable TCC weighed 1.4 kg (p=0.5 compared with the TCC).
The mean time for placement was 12.4 (+/-1.9) minutes (range: 6.9 -15.7; 95% CI: 11.7 -13.11) for the TCC and 7.6 (+/-1.6) minutes (range: 5.3 -12.5; 95% CI: 7.1 -8.1) for the irremovable TCC, (p<0.0001). This represented a 39% reduction (95% CI: 33 -47) in time with the irremovable TCC.
The mean time for removal was 3.6 (+/-0.8) minutes (range: 2 -5.3; 95% CI: 3.4 -3.8) for the TCC and 2.3 (+/-0.6) minutes (range: 1.4 -4; 95% CI: 2.1 -2.5) for the irremovable TCC, (p<0.0001). This represented a 36% reduction
